Bioatla inc BCAB.US Value Analysis

US StockHealth Care
(No presentation for BCAB)

BCAB Value Score

3

24

15

Limited Growth
  • AI analysis rates BCAB  with a lower value score of 2.
  • It is mainly due to  unstable operating cash flow, along with potential value may be lower.
  • Over the past 3 months, BCAB has maintained a consecutive value rating of 2.0, slightly higher than the rating of 0.8 over the past 3 years. However, growth opportunities for enterprise value remain relatively low.
  • Compared to all stocks in the Health Care sector, BCAB has a medium value rating.

BCAB Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/04/03 (Weekly Update)

BCAB Financial Forecast

Unit : USD

Update to 2025/5/9 (Quarterly Update)

BCAB Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.63
-
-12.5%
250K
-
-94.6%
-15,286.7%
2021Q2
-0.68
-
-26.1%
150K
-
-96.7%
-12,152.4%
2021Q1
-0.9
-
60.7%
250K
-
2.8%
0%

Update to 2025/5/10 (Quarterly Update)

BCAB Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

BCAB Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of BCAB from 2021/03 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from March, 2021 to May, 2025. (Total Trades: 0)

BCABSectorUS Overall Market
Wining Rate-45%54%
Avg Return-62.9%72.8%
Avg Profit-197.1%165.9%
Avg Loss--45.1%-34.6%
Avg Risk-Reward Ratio-437%479.2%

Update to 2025/5/10 (Daily Update)

Top 10 High Relevance to BCAB Value Score